Thermo Fisher Scientific | TMO - Current Assets


Thermo Fisher Scientific reported $25.62B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Agilent USD 4.69B 70M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bio Techne USD 744.4M 56.35M Jun/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.93B 83M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
General Electric Aerospace USD 41.53B 1.83B Sep/2026
Henry Schein USD 4.6B 104M Jun/2026
Illumina USD 2.83B 96M Jun/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Laboratory Of America USD 3.97B 151.3M Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Olympus JPY 637.48B 68.83B Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Repligen USD 1.24B 41.43M Sep/2026
Revvity USD 2.3B 169.4M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Veracyte USD 574.78M 52.6M Jun/2026
Waters USD 3.9B 186M Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026